Payment overview · 2025
General Payments
$16.34
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rayford Benard Mitchell, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · KARNES CITY, TX · NPI 1811012198
Verified facts
What the public records show
CMS Open Payments records show Rayford Benard Mitchell, M.D. received $16.34 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $16.34 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.34 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $16.34 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $16.34 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 691 | 104 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 537 | 59 |
| Amlodipine Besylate | Amlodipine Besylate | 502 | 87 |
| Atorvastatin Calcium | Atorvastatin Calcium | 477 | 85 |
| Gabapentin | Gabapentin | 428 | 54 |
| Furosemide | Furosemide | 419 | 64 |
| Lisinopril | Lisinopril | 384 | 75 |
| Losartan Potassium | Losartan Potassium | 296 | 43 |
| Metformin Hcl | Metformin Hcl | 295 | 58 |
| Pantoprazole Sodium | Pantoprazole Sodium | 291 | 43 |
| Metoprolol Tartrate | Metoprolol Tartrate | 269 | 40 |
| Escitalopram Oxalate | Escitalopram Oxalate | 257 | 33 |
| Hydrochlorothiazide | Hydrochlorothiazide | 231 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 215 | 34 |
| Alprazolam | Alprazolam | 206 | 33 |
| Simvastatin | Simvastatin | 202 | 29 |
| Mirtazapine | Mirtazapine | 148 | 17 |
| Carvedilol | Carvedilol | 143 | 26 |
| Metoprolol Succinate | Metoprolol Succinate | 143 | 32 |
| Trazodone Hcl | Trazodone Hcl | 142 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 135 | 26 |
| Tramadol Hcl | Tramadol Hcl | 132 | 24 |
| Sertraline Hcl | Sertraline Hcl | 130 | 17 |
| Meloxicam | Meloxicam | 128 | 28 |
| Buspirone Hcl | Buspirone Hcl | 123 | 13 |
| Omeprazole | Omeprazole | 123 | 21 |
| Famotidine | Famotidine | 118 | 20 |
| Myrbetriq | Mirabegron | 111 | 12 |
| Potassium Chloride | Potassium Chloride | 111 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 110 | 18 |
| Ozempic | Semaglutide | 109 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 108 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 108 | 16 |
| Zolpidem Tartrate | Zolpidem Tartrate | 101 | 12 |
| Clonazepam | Clonazepam | 98 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 97 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 91 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 90 | 16 |
| Eliquis | Apixaban | 86 | 19 |
| Spironolactone | Spironolactone | 86 | 12 |
| Diazepam | Diazepam | 84 | 11 |
| Lactulose | Lactulose | 80 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 80 | 17 |
| Donepezil Hcl | Donepezil Hcl | 78 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 77 | 12 |
| Xarelto | Rivaroxaban | 76 | suppressed |
| Chlorthalidone | Chlorthalidone | 75 | 14 |
| Risperidone | Risperidone | 74 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 71 | 19 |
| Memantine Hcl | Memantine Hcl | 70 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 66 | 19 |
| Januvia | Sitagliptin Phosphate | 66 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 66 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 64 | suppressed |
| Pregabalin | Pregabalin | 60 | 13 |
| Tradjenta | Linagliptin | 60 | 14 |
| Oxcarbazepine | Oxcarbazepine | 59 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 58 | suppressed |
| Sucralfate | Sucralfate | 57 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 57 | suppressed |
| Lorazepam | Lorazepam | 56 | suppressed |
| Nifedipine Er | Nifedipine | 56 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 56 | suppressed |
| Aripiprazole | Aripiprazole | 54 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 54 | 21 |
| Prednisone | Prednisone | 53 | 14 |
| Divalproex Sodium | Divalproex Sodium | 52 | suppressed |
| Linzess | Linaclotide | 50 | suppressed |
| Celecoxib | Celecoxib | 49 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 49 | 14 |
| Lovastatin | Lovastatin | 48 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 15 |
| Levemir Flexpen | Insulin Detemir | 45 | suppressed |
| Bupropion Xl | Bupropion Hcl | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | 13 |
| Mounjaro | Tirzepatide | 44 | suppressed |
| Lamotrigine | Lamotrigine | 43 | suppressed |
| Glipizide | Glipizide | 42 | suppressed |
| Latanoprost | Latanoprost | 42 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 42 | suppressed |
| Methocarbamol | Methocarbamol | 41 | suppressed |
| Azithromycin | Azithromycin | 40 | 34 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 40 | suppressed |
| Levetiracetam | Levetiracetam | 40 | suppressed |
| Jardiance | Empagliflozin | 38 | suppressed |
| Baclofen | Baclofen | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Enulose | Lactulose | 35 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 33 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 33 | suppressed |
| Fenofibrate | Fenofibrate | 32 | suppressed |
| Lacosamide | Lacosamide | 32 | suppressed |
| Ibuprofen | Ibuprofen | 31 | suppressed |
| Methimazole | Methimazole | 31 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 31 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 30 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 29 | 14 |
| Hydralazine Hcl | Hydralazine Hcl | 28 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 28 | suppressed |
| Topiramate | Topiramate | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 27 | suppressed |
| Dutasteride | Dutasteride | 27 | suppressed |
| Movantik | Naloxegol Oxalate | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 14 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Nitroglycerin | Nitroglycerin | 25 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Fentanyl | Fentanyl | 24 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 24 | suppressed |
| Olanzapine | Olanzapine | 24 | suppressed |
| Atenolol | Atenolol | 23 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 23 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Verapamil Sr | Verapamil Hcl | 23 | suppressed |
| Xifaxan | Rifaximin | 23 | suppressed |
| Allopurinol | Allopurinol | 22 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 22 | 15 |
| Rivastigmine | Rivastigmine Tartrate | 22 | suppressed |
| Lisdexamfetamine Dimesylate | Lisdexamfetamine Dimesylate | 21 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Silodosin | Silodosin | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Bumetanide | Bumetanide | 19 | suppressed |
| Estradiol | Estradiol | 19 | suppressed |
| Finasteride | Finasteride | 19 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 19 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 18 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 18 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Glyburide | Glyburide | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 15 |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 16 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 16 | suppressed |
| Permethrin | Permethrin | 16 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 15 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 15 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Constulose | Lactulose | 14 | suppressed |
| Fluconazole | Fluconazole | 14 | suppressed |
| Novolin R | Insulin Regular, Human | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 13 | suppressed |
| Clobazam | Clobazam | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 11 |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Methotrexate | Methotrexate Sodium | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Cefadroxil | Cefadroxil | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Euthyrox | Levothyroxine Sodium | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | suppressed |
| Neupro | Rotigotine | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Descovy | Emtricitabine/Tenofov Alafenam | 11 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 11 | suppressed |
| Synthroid | Levothyroxine Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.34 · 1 records | Amgen Inc. | OTEZLA, REPATHA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error